Nikhil Vora

Nikhil Vora General Information

Description

Mr. Nikhil Vora is a Co-Founder and serves as Chief Executive Officer at Sixth Sense Ventures. He serves as a Board Member at T.A.C - The Ayurveda Co., ProcMart, Altigreen, Phool, Khanal Foods, Open Secre, Fraazo, GoodDot, Neeman's, Soothe Healthcare, Uppercase and DesignCafe. He is also a Co-Owner of Veeda Clinical Research. He also served as a Board Member at Leap India and Fitternity. He serves as a Board Member at Vahdam, Bombay Shaving Company, and Life Healthcare. He is a consumer and finance industry veteran with over 27 years of experience. He is the Founder and CEO of Sixth Sense Ventures Advisors LLP - India's first Domestic Consumer-Centric Venture Fund. He served as a Board Member at Eupheus Learning. He was earlier the Managing Director & Head of Research at IDFC Securities. He has been invited by Nestle Global, Unilever, Aditya Birla Group, Marico, Godrej, etc. to evolve a strategic roadmap for their businesses. He specializes in identifying emerging consumer trends and his research has been accredited by global funds like Capital, Fidelity, Alliance Bernstein, Putnam, Schroder's, etc. In the Asia Money polls in 2012, he was voted as India's No.1 analyst. He also has the rare distinction of being voted Asia's Best Analyst by the Wall Street Journal in the same year. A post-graduate in Management, he was a member participant in the Future Leaders Program at the Saïd Business School, University of Oxford, London. He was also bestowed with the 'Thought Leadership' award by IDFC Ltd. Along with advising clients, he also has been an angel investor and on the board of a few of his investee companies. He has been an active angel investor, some of his investments include - One97 (PayTm), Vini Cosmetics (Fogg Deos), Parag Milk Foods (Go Cheese & Gowardhan Dairy), Kangaroo Kids, BVG India, Bewakoof Brands, Infinite Analytics, Purplle.com, Tarnea Technologies, Technology Frontiers, InCred Capital and Saucery Brands. He serves as Board Member at MyHealthcare.